Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 janv. 2023 04h23 HE | Source: Research and Markets

Global Non-Alcoholic Steatohepatitis Market Report to 2027 - Featuring Intercept Pharmaceuticals, Novartis, Siemens Healthineers and AstraZeneca Among Others

Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of...
03 janv. 2023 04h38 HE | Source: Research and Markets

Worldwide Non-Alcoholic Steatohepatitis Treatment Industry to 2030 - Featuring AstraZeneca, Conatus Pharmaceuticals, Enzo Biochem and GENFIT Among Others

Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022...
04 mai 2022 08h37 HE | Source: The Insight Partners

Non-Alcoholic Steatohepatitis (NASH) Market Worth $24.26Bn, Globally, by 2028 at 47.1% CAGR - Exclusive Report by The Insight Partners

New York, May 04, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Non-Alcoholic Steatohepatitis (NASH) Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
09 févr. 2022 05h06 HE | Source: Vantage Market Research

NASH (Non-Alcoholic Steatohepatitis) Market to Reach USD 21,879 Million by 2028 - Powered by Increasing Pharmaceutical R&D Expenditure and Escalating Obese Population- Vantage Market Research

WASHINGTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Non-Alcoholic Steatohepatitis (NASH) Market finds that growing demand for ideal NASH...
13 avr. 2021 07h13 HE | Source: Research and Markets

Global NASH Market Report 2021: Market was Valued at $3,369.12 Million in 2020 - Forecast to 2026

Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and...
23 mars 2021 08h08 HE | Source: Research and Markets

Global Non-alcoholic Steatohepatitis (NASH) Market 2021-2038: Increased Competition from New Product Launches will Shape the NASH Market

Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038" report has been added to ResearchAndMarkets.com's offering. There are...
01 janv. 2021 19h15 HE | Source: The Rosen Law Firm PA

ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
03 déc. 2020 19h45 HE | Source: The Rosen Law Firm PA

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT

NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
14 oct. 2020 04h04 HE | Source: Research and Markets

Global Primary Sclerosing Cholangitis Market 2017-2020 & 2030 Featuring Gilead Sciences, HighTide Biopharma, NGM Biopharmaceuticals, Intercept Pharmaceuticals, Dr Falk Pharma

Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Primary Sclerosing Cholangitis - Market Insights, Epidemiology and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. ...

Page précédente